Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-013250
Filing Date
2024-10-11
Accepted
2024-10-11 09:00:15
Documents
6
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20241122xdef14a.htm DEF 14A 671157
2 GRAPHIC tmb-20241122xdef14a_a005.jpg GRAPHIC 5458
3 GRAPHIC tmb-20241122xdef14a_bg001.jpg GRAPHIC 134143
4 GRAPHIC tmb-20241122xdef14a_bg002.jpg GRAPHIC 158891
5 GRAPHIC tmb-20241122xdef14a_cg001.jpg GRAPHIC 169189
6 GRAPHIC tmb-20241122xdef14a_cg002.jpg GRAPHIC 146480
  Complete submission text file 0001558370-24-013250.txt   1519162
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-49908 | Film No.: 241366497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)